BlackRock Fund Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

BlackRock Fund Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$90K	Buy	38,641 +8,640	+29%	+$16.5K	﹤0.01%	3636
2016 Q3	$50K	Buy	30,001 +3,159	+12%	+$3.87K	﹤0.01%	3779
2016 Q2	$28K	Sell	26,842 -3,994,330	-99%	-$3.86M	﹤0.01%	3876
2016 Q1	$3.5M	Sell	4,021,172 -86,313	-2%	-$83.5K	﹤0.01%	2912
2015 Q4	$4.97M	Buy	4,107,485 +78,174	+2%	+$109K	﹤0.01%	2837
2015 Q3	$6.85M	Buy	4,029,311 +68,979	+2%	+$135K	﹤0.01%	2598
2015 Q2	$8.24M	Buy	3,960,332 +652,361	+20%	+$1.58M	﹤0.01%	2619
2015 Q1	$8.96M	Buy	3,307,971 +64,194	+2%	+$163K	﹤0.01%	2500
2014 Q4	$8.34M	Buy	3,243,777 +429,797	+15%	+$965K	﹤0.01%	2566
2014 Q3	$5.15M	Sell	2,813,980 -85,306	-3%	-$186K	﹤0.01%	2739
2014 Q2	$7.74M	Sell	2,899,286 -273,537	-9%	-$823K	﹤0.01%	2576
2014 Q1	$11.1M	Buy	3,172,823 +94,523	+3%	+$419K	﹤0.01%	2340
2013 Q4	$13.8M	Sell	3,078,300 -114,635	-4%	-$467K	﹤0.01%	2195
2013 Q3	$13M	Buy	3,192,935 +382,914	+14%	+$1.67M	﹤0.01%	2205
2013 Q2	$11.7M	Buy	+2,810,021	New	+$10.9M	﹤0.01%	2172

Other funds holding ATRS

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return